Cargando…

Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis

BACKGROUND: Toxoplasma gondii, an obligate intracellular apicomplexan parasite, infects a wide range of warm-blooded animals including humans. T. gondii expresses five members of the C1 family of cysteine proteases, including cathepsin B-like (TgCPB) and cathepsin L-like (TgCPL) proteins. TgCPB is i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Guanghui, Zhou, Aihua, Lv, Gang, Meng, Min, Sun, Min, Bai, Yang, Han, Yali, Wang, Lin, Zhou, Huaiyu, Cong, Hua, Zhao, Qunli, Zhu, Xing-Quan, He, Shenyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659040/ https://www.ncbi.nlm.nih.gov/pubmed/23651838 http://dx.doi.org/10.1186/1471-2334-13-207

Ejemplares similares

Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice
por: Han, Yali, et al.
Publicado: (2017)

DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice
por: Meng, Min, et al.
Publicado: (2013)

Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii
por: Lu, Gang, et al.
Publicado: (2014)

Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice
por: Meng, Min, et al.
Publicado: (2012)

Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice
por: Guo, Jingjing, et al.
Publicado: (2019)

Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice
por: Han, Yali, et al.
Publicado: (2017)

Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice
por: Cong, Hua, et al.
Publicado: (2014)

Sequence Variation in Superoxide Dismutase Gene of Toxoplasma gondii among Various Isolates from Different Hosts and Geographical Regions
por: Wang, Shuai, et al.
Publicado: (2015)

Compound DNA vaccine encoding SAG1/ SAG3 with A(2)/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii
por: Cong, Hua, et al.
Publicado: (2013)

Diagnosis of toxoplasmosis and typing of Toxoplasma gondii
por: Liu, Quan, et al.
Publicado: (2015)

Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice
por: Liu, Yuan, et al.
Publicado: (2017)

Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii
por: Song, Pengxia, et al.
Publicado: (2017)

A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection
por: Yin, Huiquan, et al.
Publicado: (2015)

Characterization of exosomes derived from Toxoplasma gondii and their functions in modulating immune responses
por: Li, Yawen, et al.
Publicado: (2018)

Toxoplasma gondii infection in humans in China
por: Zhou, Peng, et al.
Publicado: (2011)

Role of amylopectin synthesis in Toxoplasma gondii and its implication in vaccine development against toxoplasmosis
por: Lyu, Congcong, et al.
Publicado: (2021)

Toxoplasma gondii infection and toxoplasmosis in North Africa: a review
por: Rouatbi, Mariem, et al.
Publicado: (2019)

Undeveloped Mammæ
por: Mask, W. B.
Publicado: (1894)

The Undeveloped Case
por: Kent, J. T.
Publicado: (1885)

Analysis of Structures and Epitopes of Surface Antigen Glycoproteins Expressed in Bradyzoites of Toxoplasma gondii
por: Cong, Hua, et al.
Publicado: (2013)

Genetic Divergence of Toxoplasma gondii Strains Associated with Ocular Toxoplasmosis, Brazil
por: Khan, Asis, et al.
Publicado: (2006)

Toxoplasma gondii Recombinant Antigens in the Serodiagnosis of Toxoplasmosis in Domestic and Farm Animals
por: Ferra, Bartłomiej, et al.
Publicado: (2020)

Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii
por: Zhou, Jian, et al.
Publicado: (2016)

Identification of Toxoplasma Gondii Tyrosine Hydroxylase (TH) Activity and Molecular Immunoprotection against Toxoplasmosis
por: Zhang, Zhenchao, et al.
Publicado: (2020)

A cathepsin C-like protease post-translationally modifies Toxoplasma gondii secretory proteins for optimal invasion and egress
por: Thornton, L. Brock, et al.
Publicado: (2023)

Severe Acquired Toxoplasmosis Caused by Wild Cycle of Toxoplasma gondii, French Guiana
por: Carme, Bernard, et al.
Publicado: (2009)

The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis
por: Brown, Kevin M., et al.
Publicado: (2009)

Effects of Toxoplasma gondii Infection in Level of Serum Testosterone in Males with Chronic Toxoplasmosis
por: ESLAMIRAD, Zahra, et al.
Publicado: (2013)

Genotyping of Toxoplasma gondii Strains Isolated from Patients with Ocular Toxoplasmosis in Iran
por: NOROUZI, Maryam, et al.
Publicado: (2016)

Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis
por: Palencia, Andrés, et al.
Publicado: (2017)

Experimental Porcine Toxoplasma gondii Infection as a Representative Model for Human Toxoplasmosis
por: Nau, Julia, et al.
Publicado: (2017)

Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact
por: Stelzer, S., et al.
Publicado: (2019)

Application of Toxoplasma gondii-specific SAG1, GRA7 and BAG1 proteins in serodiagnosis of animal toxoplasmosis
por: Qi, Tongsheng, et al.
Publicado: (2022)

A cathepsin C-like protease mediates the post-translation modification of Toxoplasma gondii secretory proteins for optimal invasion and egress
por: Thornton, L. Brock, et al.
Publicado: (2023)

Toxoplasma gondii α‐amylase deletion mutant is a promising vaccine against acute and chronic toxoplasmosis
por: Yang, Jing, et al.
Publicado: (2020)

Genetic Characterization of Toxoplasma gondii Isolates and Toxoplasmosis Seroprevalence in Stray Cats of İzmir, Turkey
por: Can, Hüseyin, et al.
Publicado: (2014)

Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis
por: Yin, Li-Tian, et al.
Publicado: (2013)

Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor
por: Choi, Won Hyung, et al.
Publicado: (2018)

Anti-Toxoplasma gondii IgG avidity testing is necessary for diagnosis of acute toxoplasmosis
por: Nasir, Idris-Abdullahi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ovvgs06mkdfv9e32dndmol0tbh